Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Raf kinase | 0.2579 | 0.6435 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.3242 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.1913 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.3187 | 0.9706 | 0.9706 |
Loa Loa (eye worm) | raf kinase | 0.266 | 0.6866 | 0.6627 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.3187 | 0.9706 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.3242 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.3187 | 0.9706 | 0.9706 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.1913 | 0.2852 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Onchocerca volvulus | 0.3242 | 1 | 0.5 | |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.1913 | 0.2852 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3187 | 0.9706 | 0.9706 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.3242 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1859 | 0.2557 | 0.1988 |
Loa Loa (eye worm) | hypothetical protein | 0.3187 | 0.9706 | 0.9683 |
Giardia lamblia | Hypothetical protein | 0.1913 | 0.2852 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1913 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.